Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Carey

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
The Oncologist|February 1, 2011
Directed therapy of subtypes of triple-negative breast cancerLisa A Carey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Targeted chemotherapy? Platinum in BRCA1-dysfunctional breast cancerLisa A Carey
Breast (Edinburgh, Scotland)|July 11, 2017
De-escalating and escalating systemic therapy in triple negative breast cancerLisa A Carey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Neoadjuvant trials of human epidermal growth factor receptor 2 targeting: how many drugs do we need?Lisa A Carey
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Novel targets for triple-negative breast cancerLisa A Carey
Transactions of the American Clinical and Climatological Association|August 7, 2025
BREAST CANCER: STEPS AND STUMBLES ON THE WAY TO PRECISION MEDICINELisa A Carey
Nature Reviews. Clinical Oncology|March 14, 2012
Breast cancer: HER2--a good addictionLisa A Carey
Nature Cancer|February 5, 2022
Finding the positive in triple-negative breast cancerLisa A Carey
The Oncologist|December 9, 2010
Directed therapy of subtypes of triple-negative breast cancerLisa A Carey
Clinical Breast Cancer|May 26, 2010
Through a glass darkly: advances in understanding breast cancer biology, 2000-2010Lisa A Carey
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
The Oncologist|February 1, 2011
Directed therapy of subtypes of triple-negative breast cancerLisa A Carey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Targeted chemotherapy? Platinum in BRCA1-dysfunctional breast cancerLisa A Carey
Breast (Edinburgh, Scotland)|July 11, 2017
De-escalating and escalating systemic therapy in triple negative breast cancerLisa A Carey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Neoadjuvant trials of human epidermal growth factor receptor 2 targeting: how many drugs do we need?Lisa A Carey
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Novel targets for triple-negative breast cancerLisa A Carey
Transactions of the American Clinical and Climatological Association|August 7, 2025
BREAST CANCER: STEPS AND STUMBLES ON THE WAY TO PRECISION MEDICINELisa A Carey
Nature Reviews. Clinical Oncology|March 14, 2012
Breast cancer: HER2--a good addictionLisa A Carey
Nature Cancer|February 5, 2022
Finding the positive in triple-negative breast cancerLisa A Carey
The Oncologist|December 9, 2010
Directed therapy of subtypes of triple-negative breast cancerLisa A Carey
Clinical Breast Cancer|May 26, 2010
Through a glass darkly: advances in understanding breast cancer biology, 2000-2010Lisa A Carey
Pageof 32